• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 217/02 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ringAlkylene-bis-isoquinolines

Patent holdings for IPC class C07D 217/02

Total number of patents in this class: 392

10-year publication summary

30
25
31
20
30
27
20
21
23
7
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Alcon, Inc.
5425
28
Aerie Pharmaceuticals, Inc.
50
9
Bausch + Lomb Ireland Limited
691
9
Pfizer Inc.
3387
7
Centre National de La Recherche Scientifique
10418
7
D. Western Therapeutics Institute, Inc.
19
7
Universite de Montpellier
985
7
The Regents of the University of California
19918
5
Janssen Pharmaceutica N.V.
3392
5
Abivax
119
5
Institut Curie
584
5
Bristol-myers Squibb Company
4898
4
Merck Patent GmbH
5831
4
Epizyme, Inc.
370
4
Icahn School of Medicine at Mount Sinai
946
4
The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin
163
4
The University of Queensland
660
4
Fosun Orinove Pharmatech, Inc.
13
4
Woolsey Pharmaceuticals, Inc.
79
4
Allergan, Inc.
2349
3
Other owners 263